US FDA Rejects Novartis Heart Failure Drug, Demands More Data The Westside Story There is bad news for Drug Manufacturer Novartis. Its latest drug known presently as RLX030 and showed promise in Stage II testing has been rejected by the US FDA which stated that there is need for some more testing and more data before the drug can ... |
